Art

J-GLOBAL ID：201902214613162240   Reference number：19S0683811

Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly

Author (10)： Matsumoto, T. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Yokota, K. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Sawada, M. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Sakakibara, A. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Shibata, S. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Yasue, S. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Tomita, Y. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Akiyama, M. (Department of Dermatology, Nagoya University Graduate School of Medicine) ,  Yatsuya, H. (Department of Public Health and Health Systems, Nagoya University Graduate School of Medicine) ,  Yatsuya, H. (Department of Public Health, Fujita Health University)
Material： Journal of the European Academy of Dermatology and Venereology
Volume： 27  Issue： 12  Page： 1514-1520  Publication year： 2013 
JST Material Number： SCOPUS  ISSN： 0926-9959  CODEN： JEAVE 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Terms in the title (1)： IMPROVE